Risk Management

February 2021 Bulletin: COVID-19 Vaccinations

Some policyholders have expressed interest in administering COVID-19 vaccines. Vaccination services are complex, especially for physicians who do not customarily vaccinate patients. The COVID-19 vaccine landscape is also dynamic: different vaccines, different dosing schedules, and varying availability of vaccines add to the challenge of providing this service.
In response, OMIC has created a resource outlining medical professional liability risks associated with offering the COVID-19 vaccine and recommendations to mitigate those risks https://www.omic.com/covid-19-vaccine-risk-management-considerations-and-consent/. The resource also includes a sample patient screening and vaccination consent form.

If you have questions about these risk management resources, contact us for confidential risk management advice by emailing us at riskmanagement@omic.com.

OMIC is extending coverage to its insureds for the administration of COVID19 vaccinations. Questions about coverage should be directed to OMIC’s Underwriting Department at (800) 562-6642, ext. 1, or omic@omic.com.

Thank you,

Linda D. Harrison, PhD
Vice President, OMIC Risk Management

Please refer to OMIC's Copyright and Disclaimer regarding the contents on this website

Leave a comment

Six reasons OMIC is the best choice for ophthalmologists in America.

Consistent return of premium.

Publicly-traded insurance companies exist to make profits for shareholders while physician-owned carriers often return profits to their policyholders. Don’t underestimate this benefit; it can add up to tens of thousands of dollars over the course of your career. OMIC has one of the most generous dividend programs for ophthalmologists and has returned more than $90 Million to our members through dividends.